Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bendamustine”

333 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 333 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03336333
What this trial is testing

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeiGene 590
Testing effectiveness (Phase 2)Study completedNCT00547534
What this trial is testing

Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
University of Rochester 31
Large-scale testing (Phase 3)UnknownNCT01570049
What this trial is testing

Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma by Clinical Course
Shandong Lanjin Pharmaceuticals Co.,Ltd 100
Not applicableNot Yet RecruitingNCT06757478
What this trial is testing

A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma

Who this might be right for
Lymphoma Patient
First Affiliated Hospital of Ningbo University 30
Testing effectiveness (Phase 2)WithdrawnNCT02623920
What this trial is testing

Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaMediastinal Large B-cell LymphomaGrey Zone Lymphoma+4 more
University of Arizona
Early research (Phase 1)Study completedNCT02728531
What this trial is testing

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Washington University School of Medicine 18
Early research (Phase 1)Study completedNCT02162888
What this trial is testing

A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients

Who this might be right for
Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
Eagle Pharmaceuticals, Inc. 81
Testing effectiveness (Phase 2)Study completedNCT02224729
What this trial is testing

Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Sidney Kimmel Cancer Center at Thomas Jefferson University 24
Early research (Phase 1)Study completedNCT01594229
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT01244451
What this trial is testing

GIMEMA CLL0809 Study (BendOfa)

Who this might be right for
Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; orPatients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines
Gruppo Italiano Malattie EMatologiche dell'Adulto 49
Testing effectiveness (Phase 2)Study completedNCT03259529
What this trial is testing

Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)WithdrawnNCT04607772
What this trial is testing

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Study completedNCT03900377
What this trial is testing

Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma

Who this might be right for
Lymphoma, B-cell, Diffuse
SymBio Pharmaceuticals 37
Large-scale testing (Phase 3)Study completedNCT02763319
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 453
Not applicableStudy completedNCT06295211
What this trial is testing

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Who this might be right for
Hodgkin Lymphoma
Federico II University 32
Testing effectiveness (Phase 2)Looking for participantsNCT05868395
What this trial is testing

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle-cell Lymphoma
Medical University of Vienna 16
Not applicableStudy completedNCT01224769
What this trial is testing

Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders

Who this might be right for
Relapsed or Refractory Chronic Lymphoproliferative Disorders
Gruppo Italiano Studio Linfomi 109
Testing effectiveness (Phase 2)Study completedNCT01874054
What this trial is testing

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Seagen Inc. 55
Testing effectiveness (Phase 2)Looking for participantsNCT03980002
What this trial is testing

A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Study completedNCT02689986
What this trial is testing

Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease

Who this might be right for
Cold Agglutinin DiseaseAutoimmune Hemolytic Anemia
Helse Fonna 43
Load More Results